Canada markets closed

Takeda Pharmaceutical Company Limited (TKD.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
24.54+0.33 (+1.36%)
At close: 12:59PM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 38.63B
Enterprise Value 64.64B
Trailing P/E 44.63
Forward P/E 1.43k
PEG Ratio (5 yr expected) 51.42
Price/Sales (ttm)1.51
Price/Book (mrq)0.88
Enterprise Value/Revenue 2.55
Enterprise Value/EBITDA 10.86

Trading Information

Stock Price History

Beta (5Y Monthly) 0.54
52-Week Change 3-19.97%
S&P500 52-Week Change 326.49%
52 Week High 330.99
52 Week Low 324.00
50-Day Moving Average 325.35
200-Day Moving Average 326.58

Share Statistics

Avg Vol (3 month) 3207
Avg Vol (10 day) 3347
Shares Outstanding 51.57B
Implied Shares Outstanding 61.6B
Float 81.55B
% Held by Insiders 10.03%
% Held by Institutions 144.96%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 41.18
Forward Annual Dividend Yield 44.87%
Trailing Annual Dividend Rate 3188.00
Trailing Annual Dividend Yield 3776.54%
5 Year Average Dividend Yield 44.73
Payout Ratio 4206.23%
Dividend Date 3N/A
Ex-Dividend Date 4Sept 27, 2024
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in JPY.

Fiscal Year

Fiscal Year Ends Mar 31, 2024
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 3.38%
Operating Margin (ttm)-7.40%

Management Effectiveness

Return on Assets (ttm)1.57%
Return on Equity (ttm)2.12%

Income Statement

Revenue (ttm)4.26T
Revenue Per Share (ttm)2,725.41
Quarterly Revenue Growth (yoy)9.90%
Gross Profit (ttm)N/A
EBITDA 1.09T
Net Income Avi to Common (ttm)144.07B
Diluted EPS (ttm)0.54
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)457.8B
Total Cash Per Share (mrq)291.78
Total Debt (mrq)5.53T
Total Debt/Equity (mrq)76.05%
Current Ratio (mrq)1.11
Book Value Per Share (mrq)4,635.56

Cash Flow Statement

Operating Cash Flow (ttm)716.34B
Levered Free Cash Flow (ttm)35.08B